Robert J. Weiland Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert J. Weiland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert J. Weiland. Robert J. Weiland is a Director in CymaBay Therapeutics, Inc. ($CBAY) and a Chief Commercial Officer in Pacira Pharmaceuticals, Inc. ($PCRX).
Address: C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY 07054 NJ
Companies in which Robert J. Weiland is an Insider
CymaBay Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Weiland: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 31 2019
$CBAY Market Capitalization: $52.52M
$CBAY Previous Close: $2.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Weiland: Chief Commercial Officer
Holdings: 5,088 shares
Current Value: $212,424
Latest Transaction: Jun 06 2018
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert J. Weiland
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Sell | S | 33.02 | 373 | 12,316 | 5,088 | 5.5 K to 5.1 K (-6.83 %) |
| Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
| Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
| Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 44.20 | 9,000 | 397,800 | 9,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 4,864 | 364 to 4.9 K (+1,236.26 %) |